Cresset Asset Management LLC Sells 7,502 Shares of Danaher Corporation $DHR

Key Points

• Cresset Asset Management LLC reduced its stake in Danaher Corporation by 15.2%, selling 7,502 shares in the first quarter, leaving them with 42,014 shares valued at approximately $8.63 million.
• Several hedge funds, including Vanguard Group and Bank of New York Mellon Corp, have increased their positions in Danaher, reflecting strong institutional interest as 79.05% of the stock is now owned by institutional investors.
• Danaher Corporation reported $1.80 earnings per share for the last quarter, exceeding expectations and showing a 3.4% revenue increase year-over-year.

Cresset Asset Management LLC decreased its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 15.2% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 42,014 shares of the conglomerate's stock after selling 7,502 shares during the quarter. Cresset Asset Management LLC's holdings in Danaher were worth $8,626,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the business. FAS Wealth Partners Inc. lifted its position in shares of Danaher by 20.6% in the 4th quarter. FAS Wealth Partners Inc. now owns 9,597 shares of the conglomerate's stock worth $2,203,000 after acquiring an additional 1,639 shares during the period. MGO One Seven LLC lifted its position in shares of Danaher by 485.7% in the 1st quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate's stock worth $5,145,000 after acquiring an additional 20,813 shares during the period. Asahi Life Asset Management CO. LTD. bought a new stake in shares of Danaher in the 1st quarter worth approximately $539,000. Horizon Financial Services LLC lifted its position in shares of Danaher by 20,400.0% in the 1st quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate's stock worth $1,681,000 after acquiring an additional 8,160 shares during the period. Finally, EFG Asset Management Americas Corp. lifted its position in shares of Danaher by 13.1% in the 1st quarter. EFG Asset Management Americas Corp. now owns 36,080 shares of the conglomerate's stock worth $7,396,000 after acquiring an additional 4,191 shares during the period. Institutional investors own 79.05% of the company's stock.

Danaher Price Performance

DHR traded up $7.8060 during trading on Friday, hitting $211.7060. The company's stock had a trading volume of 2,504,855 shares, compared to its average volume of 4,217,028. The firm's 50 day moving average price is $200.45 and its two-hundred day moving average price is $199.55. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $279.90. The stock has a market capitalization of $151.59 billion, a price-to-earnings ratio of 45.04, a price-to-earnings-growth ratio of 2.95 and a beta of 0.73.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The firm had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. During the same quarter in the previous year, the company posted $1.72 EPS. The business's revenue for the quarter was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Sell-side analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research firms recently weighed in on DHR. Deutsche Bank Aktiengesellschaft lowered their target price on shares of Danaher from $240.00 to $235.00 in a research note on Thursday, June 5th. HSBC lowered their target price on shares of Danaher from $270.00 to $240.00 in a research note on Friday, April 25th. Wall Street Zen upgraded Danaher from a "hold" rating to a "buy" rating in a research report on Friday, June 27th. Scotiabank upgraded Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 target price for the company in a research report on Friday, July 11th. Finally, UBS Group cut their target price on Danaher from $240.00 to $225.00 and set a "buy" rating for the company in a research report on Wednesday, July 23rd. Seventeen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, Danaher presently has an average rating of "Moderate Buy" and an average target price of $247.61.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.